In Vitro Cytotoxicity of Recombinant Human-TNF-α and Actinomycin D on Canine Normal and Tumor Cells

Journal of Veterinary Medical Science

Volumn 60, Issue 10, 1998, Pages 1087-1091

  Aoki, Mica ^a   Kuwamura, Mitsuru ^a   Kotani, Takao ^a   Katamoto, Hiromu ^a   Kubo, Kihei ^a   Nomura, Koichi ^a   Sasaki, Nobuo ^b   Ohashi, Fumihito ^a  

^a Osaka Prefecture University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

ACT D; Canine; Cytotoxicity; rh TNF ; Tumor cell

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DACTINOMYCIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; KIDNEY; KIDNEY TUMOR; MALE; PATHOLOGY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DACTINOMYCIN; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MAMMARY NEOPLASMS, ANIMAL; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032176113     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.60.1087     Document Type: Article

References (31)

1. Aoki, M., Sasaki, N., Nomura, K., Katamoto, H., Kubo, K., Kodama, H., Mukamoto, M., Shimada, M. and Ohashi, F. 1998. Cytotoxicity induced by recombinant human tumor necrosis factor-α dependent on the types of its receptors on canine cells. J. Vet. Med. Sci. (in press)
2. Asanuma, F., Yamada, Y., Kawamura, E., Yamada, T., Suzuki, T., Fujinaga, S., Kubota, T. Ishibiki, K. and Abe, O. 1991. Enzymatic preparation and role of dose-response curve in succinic dehydrogenase inhibition (SDI) chemosensitivity test for solid tumors. J. Jpn. Soc. Cancer Ther. 26: 1095-1103 (in Japanese with English summary).
3. Barabara, J. A. J., Smith, W. B., Gamble, J. R. Van Ostade, X., Vandenabeele, P., Tavernier,J., Fiers, W., Vadas, M. A. and Lopez, A. F. 1994. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selectiveTNF-α mutants. EMBO J. 13: 843-850.
4. Carswell, E., Old, L. J.,Kassel, R. L., Green, S., Fiore, N. and Williamson, B. 1975. An endotoxin-indueed serum factor that cause necrosis of tumors. Proc. Natl. Acad. Sci., U.S.A. 72: 3666-3670.
5. Creasey, A. A., Doyle, L. V., Reynolds, T., Jung, T., Lin, L. S. and Vitt, C. R. 1987. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res. 47: 145-149.
6. Economou, J. S., McBride, W. H., Essner, R., Rhoades, K., Golub, E., Holmes, E. C. and Morton, D. T. 1989. Tumor necrosis factor production by IL-2 activated macrophages in vitro and in vivo. J. Immunol. 67: 514-519.
7. Furman, W. L., Stother, D., McClain, K., Bell, B., Leventhal, B. and Pratt, C. B. 1993. Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumor: a pediatric oncology group study. J. Clin. Oncol. 11: 2205-2210.
8. Gutman, M., Inbar, M., Lev-Shlush, D., Abu-Abid, S., Mozes, M., Chaitchik, S., Meller, I. and Klausner, J. M. 1997. High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79: 1129-1137.
9. Hammer, A., Couto, G. and Ayl, R. 1994. Treatment of tumor-bearing dogs and cats with actinomycin D. J. Vet. Intern. Med. 8: 236-239.
10. Ishibashi, Y., Ishihara, K., Ohara, K. and Nakagawa, H. 1992. A phase II study of MHR-24 (natural human tumor necrosis factor) in the treatment of malignant tumor of the skin. Rinsholyaku 8: 775-792 (in Japanese with English summary).
11. Kato, A. and Kawasaki, M. 1990. Assay for tumor necrosis factor-bioassay. Clin. Immunol. 22: 78-85 (in Japanese).
12. Kemeny, N., Childs, B., Larchian, W., Rosado, K. and Kelsen, D. 1990. A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma. Cancer 66: 659-663.
13. Krawczyk, C. M., Verstovsek, S., Ujhazy, P., Maccubbin, D. and Ehrke, M. J. 1995. Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor α combination treatment of EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunol. Immunother. 40: 347-357.
14. Krosnick, J. A., Mule, J. J., McIntosh, J. K. and Rosenberg, S. A. 1989. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Cancer Res 49: 3729-3733.
15. Lasek, W., Giermasz, A., Kuc, K., Wandowicz, A., Feleszko, W., Golab, J., Zagozdzon, R., Stoklasa, T. and Jkobisiak, M. 1996. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor a in mice: Correlation between in vitro and in vivo results. Int. J. Cancer 66: 374-379.
16. Lienard, D., Ewalenko, P., Delmotte, J., Renard, N. and Lejeune, F. J. 1992. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limb for melanoma and sarcoma. J. Clin. Oncol. 10: 52-60.
17. MacEwen, E. G. and Withrow, S. J. 1996. Tumor of the mammary gland, pp. 356-372. In: Small Animal Clinical Oncology, 2nd ed. (Withrow, S. J. and MacEwen, E. G. eds.), W.B. Saunders Company, Philadelphia.
18. Maehara, Y., Kohnoe, S., Sakaguchi, Y., Emi, Y., Kusumoto, T., Miyamoto, K., Fukuchi, K. and Sugimachi, K. 1990. Chemosensitivity of human tumors in vitro evaluated by the succinate dehydrogenase inhibition (SDI) test. Saishin-Igaku 45 136-146 (in Japanese with English summary).
19. Milsark, I. W. and Cerami, A. 1985. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135: 3972-3977.
20. Moore, A. S., Theilen,G. H., Newell, A. D., Madewell, B. R. and Rudolf, A. R. 1991. Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms. Cancer Res. 51. 233-238.
21. Mucller, H., Flury, N. Liu, R., Scheidegger, S. and Eppenberger, U. 1996. Tumor necrosis factor and interferon are selectively cytostatic in vitro for hormone-dependent and hormone-independent human breast cancer cells. Eur. J. Cancer 32A: 2312-2318.
22. Nooijen, P. T. G. A., Manusama, E. R., Eggermont, A. M. M., Schalkwijk, L., Stavast, J., Marqut, R. L., deWaal, R. M. W. and Ruiter, D. J. 1996. Synergistic effects of TNF-α and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. Br. J. Cancer 74: 1908-1915.
23. Ogilvie, G. K. and Vail, D. M. 1994. Actinomycin D for remission in resistant canine lymphoma. J. Vet. Intern. Med. 8: 343-344.
24. Pak, A. S., Ip. G., Wright, M. A. and Young, M. R. I. 1995. Treating tumor-bearing mice with low-dose γ-interferon plus tumor necrosis factor α to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Cancer Res. 55: 885-890.
25. Sakaguchi, Y., Makino, M, Kaneko, T., Stephens, L. C., Strebel, F. R., Danhauser, L. L., Jenkins, G. N. and Bull, M. C. 1994. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cacer Res. 54: 2223-2227.
26. Sohmura, Y., Nakata, K., Yoshida, H., Kashimoto, H., Matsui, I. and Furuichi, H. 1986. Recombinant human tumor necrosis factor-II. Antitumor effect on murine and human tumors transplanted in mice. Int. J. Immunopharmac. 8: 357-368.
27. Suto, A., Kubota, T., Shimoyama, Y., Ishibiki, K. and Abe, O. 1989. MTT assay with reference to the clinical effect of chemotherapy. J. Surg. Oncol. 42: 28-32.
28. Tracey, K. J., Beutler, B., Lowry S. F., Merryweather, J., Wolpe, S., Mislsark, I. W., Hariri, R. J.,Fahey III, T. J., Zentella, A., Albert, J. D., Shires, T. and Cerami, A. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-473.
29. Wallach, D. 1997. Cell death induction by TNF a matter of self control. Trends Biochem. Sci. 22: 107-109.
30. Watanabe, N., Nutsu, Y., Umeno, H., Kuriyama, H., Neda, H., Yamauchi, N., Maeda, M. and Urushizaki, I. 1988. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 48: 2179-2183.
31. Withrow, S.J. 1996. Perianal tumors. pp. 261-267. In: Small Animal Clinical Oncology, 2nd ed. (Withrow, S. J. and MacEwen, E. G. eds.), W.B. Saunders Company, Philadelphia.